Skip to main content
Contact
Locations
Search
Menu
Practices
Back
Overview
Accounting
Antitrust & Competition
Bankruptcy & Insolvency
Class Certification
Commercial Disputes
Damages
Data Science & Statistical Modeling
Energy, Climate & Natural Resources
Environmental, Social & Governance (ESG)
ERISA
Government & Corporate Investigations
Health Care
HEOR, Epidemiology & Market Access
Insurance
Intellectual Property
International Arbitration
Labor & Employment
Media, Entertainment & Communications
Privacy & Data Security
Securities, Financial Products & Institutions
Strategy, Policy & Analytics
Surveys & Experimental Studies
Tax
Technology
Transaction & Governance Litigation
Valuation
See full list of Practices & Focus Areas
Search our site
People
Insights
Back
Overview
Cases
AG Features
Videos
Publishing
Forum
Health Care Bulletin
News & Events
Back
Overview
News
Events
About
Back
Overview
Our Work
Locations
Diversity, Equity & Inclusion
Pro Bono
Careers
Back
Overview
Career Path
What Is Economic Consulting?
Why Analysis Group?
FAQs
Publishing
Insights
Publishing
Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs
Postgrad Med. 2012 Jan; 124(1):124-32
View abstract
Authors
Bron M, Marynchenko M,
Yang H
, Yu AP,
Wu EQ
Practices
HEOR, Epidemiology & Market Access
Collapse
Search our site